Wordt geladen...
Counterpoint: Prostate-specific antigen velocity is not of value for early detection of cancer
There is firm evidence that PSA velocity is statistically associated with many prostate cancer outcomes, including those related to early detection. But clinical use of a marker depends on clinical as well as statistical significance. Before using PSA velocity to inform decisions such as whether or...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4054698/ https://ncbi.nlm.nih.gov/pubmed/23486455 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|